Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03967847Phase 3Completed
Phase 3, randomised, open-label trial of ketorolac in postoperative pain (2 arms), sponsored by University Hospitals Cleveland Medical Center. Primary endpoint: Postoperative Visual Analog Scale Scores up to 8 weeks. Started Feb 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03967847.